Latest & greatest articles for calcium

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on calcium or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on calcium and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for calcium

181. The Effect of a Total Etch Adhesive System versus Calcium Hydroxide in Pulpal Protection of Primary Molars.

The Effect of a Total Etch Adhesive System versus Calcium Hydroxide in Pulpal Protection of Primary Molars. UTCAT598, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title The Effect Of A Total Etch Adhesive System Versus Calcium Hydroxide In Pulpal Protection Of Primary Molars Clinical Question In the pediatric patient with carious lesions in primary molars, does the use of a total etch dental adhesive system (Scotchbond (...) Multipurpose) offer greater pulpal protection subsequent to cavity preparation as compared to a calcium hydroxide liner? Clinical Bottom Line The use of a total etch adhesive system offers comparable protection of the pulp complex as compared to calcium hydroxide liners. (See Comments on the CAT below) Best Evidence (you may view more info by clicking on the PubMed ID link) PubMed ID Author / Year Patient Group Study type (level of evidence) #1) Büyükgüral/2008 97 children ages 5-10 Randomized Controlled

2010 UTHSCSA Dental School CAT Library

182. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events

Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events Wang L, Manson JE, Song Y, Sesso HD CRD summary This review concluded that limited data suggested moderate-to-high doses of vitamin D supplements may reduce cardiovascular disease risk, but calcium supplements (...) may not. Given the potential for missed studies, clinical differences between studies and paucity of good quality data, the reliability of the pooled results is uncertain. However, the authors' conclusions seemed suitably cautious. Authors' objectives To assess whether vitamin D and calcium supplements reduced the risk for cardiovascular events in adults. Searching MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) were searched for studies published in English from 1966

2010 DARE.

183. Do calcium channel blockers increase the diagnosis of heart failure in patients with hypertension?

Do calcium channel blockers increase the diagnosis of heart failure in patients with hypertension? Do calcium channel blockers increase the diagnosis of heart failure in patients with hypertension? Do calcium channel blockers increase the diagnosis of heart failure in patients with hypertension? Shibata MC, Leon H, Chatterley T, Dorgan M, Vandermeer B CRD summary The review concluded that the results suggested patients with hypertension treated with calcium channel blockers had an increased (...) incidence of heart failure, but that this effect should be researched further. Despite some potential limitations with the review process, and uncertain definitions of heart failure in the included trials (noted by the authors), the authors’ cautious conclusions reflect the evidence presented. Authors' objectives To evaluate whether the use of calcium channel blockers increase the risk of heart failure in patients with hypertension. Searching PubMed (from 1950), EMBASE (from 1988), International

2010 DARE.

184. Supplemental calcium in the chemoprevention of colorectal cancer: a systematic review and meta-analysis

Supplemental calcium in the chemoprevention of colorectal cancer: a systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2010 DARE.

185. Systematic review: Muscle cramps: quinine derivatives likely to be effective but not recommended for routine use due to toxicity; vitamin B complex, naftidrofuryl and calcium channel blockers possibly effective

Systematic review: Muscle cramps: quinine derivatives likely to be effective but not recommended for routine use due to toxicity; vitamin B complex, naftidrofuryl and calcium channel blockers possibly effective Muscle cramps: quinine derivatives likely to be effective but not recommended for routine use due to toxicity; vitamin B complex, naftidrofuryl and calcium channel blockers possibly effective | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content (...) are here Muscle cramps: quinine derivatives likely to be effective but not recommended for routine use due to toxicity; vitamin B complex, naftidrofuryl and calcium channel blockers possibly effective Article Text Therapeutics Systematic review Muscle cramps: quinine derivatives likely to be effective but not recommended for routine use due to toxicity; vitamin B complex, naftidrofuryl and calcium channel blockers possibly effective Gavin Young Statistics from Altmetric.com Commentary on: Katzberg HD

2010 Evidence-Based Medicine

186. Case control: The use of diuretics plus calcium channel blockers for hypertension may be associated with a higher risk of myocardial infarction but not stroke compared with the combination of diuretics plus ? blockers Full Text available with Trip Pro

Case control: The use of diuretics plus calcium channel blockers for hypertension may be associated with a higher risk of myocardial infarction but not stroke compared with the combination of diuretics plus ? blockers The use of diuretics plus calcium channel blockers for hypertension may be associated with a higher risk of myocardial infarction but not stroke compared with the combination of diuretics plus β blockers | BMJ Evidence-Based Medicine We use cookies to improve our service (...) name or password? You are here The use of diuretics plus calcium channel blockers for hypertension may be associated with a higher risk of myocardial infarction but not stroke compared with the combination of diuretics plus β blockers Article Text Treatment Case control The use of diuretics plus calcium channel blockers for hypertension may be associated with a higher risk of myocardial infarction but not stroke compared with the combination of diuretics plus β blockers Rhonda M Cooper-DeHoff

2010 Evidence-Based Medicine

187. The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk Full Text available with Trip Pro

The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk This study sought to examine the relationship between coronary artery calcium score (CACS) and single-photon emission computed tomography (SPECT) results for predicting the short- and long-term risk of cardiac events.The CACS and SPECT results both provide important prognostic information. It is unclear whether integrating these tests will better predict

2009 EvidenceUpdates

188. Prognostic accuracy of B-natriuretic peptide measurements and coronary artery calcium in asymptomatic subjects (from the Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research [EISNER] study) (Abstract)

Prognostic accuracy of B-natriuretic peptide measurements and coronary artery calcium in asymptomatic subjects (from the Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research [EISNER] study) B-type natriuretic peptide (BNP) has prognostic implications in patients with acute and chronic cardiac symptoms. Its prognostic role in asymptomatic patients with evidence of subclinical disease remains unclear. The population of this study included 2,458 asymptomatic adults (...) (47% women) with an average Framingham risk score of 8.8 +/- 7% who underwent computed tomographic evaluation of coronary artery calcium (CAC). BNP levels were measured using the Triage CardioProfilER panel method. Cox proportional-hazards models were used to estimate time to a cardiovascular (CV) event (n = 84; 16 deaths, 12 myocardial infarctions, 8 cerebrovascular accidents or transient ischemic attacks, and 48 diagnoses of incident symptomatic coronary disease). Relative risk was calculated

2009 EvidenceUpdates

189. Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer (Abstract)

Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer Current methods of preoperative staging and predicting outcome following pancreatectomy for pancreatic cancer (PC) are inadequate. We evaluated the utility of multiple biomarkers from distinct biologic pathways as potential predictive markers of response to pancreatectomy and patient survival.We assessed the relationship of candidate biomarkers known, or suspected, to be aberrantly expressed

2009 EvidenceUpdates

190. Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis) Full Text available with Trip Pro

Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis) In this study, we aimed to establish whether age-sex-specific percentiles of coronary artery calcium (CAC) predict cardiovascular outcomes better than the actual (absolute) CAC score.The presence and extent of CAC correlates with the overall magnitude of coronary atherosclerotic plaque burden and with the development of subsequent coronary

2009 EvidenceUpdates

191. Calcium and bone health: position statement for the Australian and New Zealand Bone and Mineral Society, Osteoporosis Australia and the Endocrine Society of Australia Full Text available with Trip Pro

Calcium and bone health: position statement for the Australian and New Zealand Bone and Mineral Society, Osteoporosis Australia and the Endocrine Society of Australia Calcium and bone health: position statement for the Australian and New Zealand Bone and Mineral Society, Osteoporosis Australia and the Endocrine Society of Australia | The Medical Journal of Australia mja-search search Use the for more specific terms. Title contains Body contains Date range from Date range to Article type (...) Author's surname Volume First page doi: 10.5694/mja__.______ Search Reset  close Individual Login Purchase options Connect person_outline Login keyboard_arrow_down Individual Login Purchase options menu search Advertisement close Calcium and bone health: position statement for the Australian and New Zealand Bone and Mineral Society, Osteoporosis Australia and the Endocrine Society of Australia Kerrie M Sanders, Caryl A Nowson, Mark A Kotowicz, Kathryn Briffa, Amanda Devine and Ian R Reid Med J Aust

2009 MJA Clinical Guidelines

192. Class Act: Cardiac CT to Assess Coronary Artery Calcium

Class Act: Cardiac CT to Assess Coronary Artery Calcium Class Act: Cardiac CT to Assess Coronary Artery Calcium – Clinical Correlations Search Class Act: Cardiac CT to Assess Coronary Artery Calcium May 17, 2009 5 min read Matthew Nayor Faculty Peer Reviewed The patient: a 55 year old male nonsmoker with an HDL of 46, LDL of 120, triglycerides of 70, BP of 135/80 (on meds) and total cholesterol of 180. (Framingham 10-year risk of MI = 12%) Coronary artery disease is the leading cause of death (...) intermediate-risk patients are at greater risk and might benefit from more aggressive preventive measures. One such possibility is the use of cardiac CT to assess coronary artery calcium (CAC). Coronary artery calcifications are absent in normal vessels, but are highly correlated with coronary artery disease (CAD). They are therefore pathognomonic for atherosclerosis and can now be reliably detected by CT scanning. When these scans are evaluated, the patient is assigned a score that represents the coronary

2009 Clinical Correlations

193. The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis

The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

194. Racial differences in blood pressure response to calcium channel blocker monotherapy: a meta-analysis

Racial differences in blood pressure response to calcium channel blocker monotherapy: a meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

195. Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers

Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

196. Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients

Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

197. Vitamin D and calcium: a systematic review of health outcomes

Vitamin D and calcium: a systematic review of health outcomes Vitamin D and calcium: a systematic review of health outcomes Vitamin D and calcium: a systematic review of health outcomes Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J, Lichtenstein A, Patel K, Raman G, Tatsioni A, Terasawa T, Trikalinos TA Citation Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J, Lichtenstein A, Patel K, Raman G, Tatsioni A, Terasawa T, Trikalinos TA. Vitamin D and calcium: a systematic review of health outcomes (...) . Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Report/Technology Assessment No. 183. 2009 Authors' conclusions The majority of the findings concerning vitamin D, calcium, or a combination of both nutrients on the different health outcomes were inconsistent. Synthesizing a dose-response relation between intake of either vitamin D, calcium, or both nutrients and health outcomes in this heterogeneous body of literature proved challenging. Timeliness warning This report has been

2009 Health Technology Assessment (HTA) Database.

198. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial. (Abstract)

Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial. Medical treatment for diabetic retinopathy could have an important role in prevention of complications such as visual loss. We aimed to assess the effect of calcium dobesilate on occurrence of diabetic macular oedema.We undertook a randomised, double-blind, placebo-controlled, multicentre study in 40 centres in 11 countries. We enrolled (...) outpatients with adult-onset type 2 diabetes and mild-to-moderate non-proliferative diabetic retinopathy, and randomly allocated them via sealed envelopes either calcium dobesilate (1500 mg per day) or placebo. The primary endpoint was development of clinically significant macular oedema (CSME) within a follow-up period of 5 years. Patients who dropped out of the study early were censored. Analysis was by intention to treat.We enrolled 635 patients. 324 were randomly allocated calcium dobesilate and 311

2009 Lancet Controlled trial quality: predicted high

199. Can calcium chemoprevention of adenoma recurrence substitute or serve as an adjunct for colonoscopic surveillance? Full Text available with Trip Pro

Can calcium chemoprevention of adenoma recurrence substitute or serve as an adjunct for colonoscopic surveillance? Can calcium chemoprevention of adenoma recurrence substitute or serve as an adjunct for colonoscopic surveillance? Can calcium chemoprevention of adenoma recurrence substitute or serve as an adjunct for colonoscopic surveillance? Shaukat A, Parekh M, Lipscomb J, Ladabaum U Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion (...) on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study examined the cost-effectiveness of calcium instead of or in addition to surveillance, in 50-year-old patients immediately after polypectomy, for the prevention of adenoma recurrence and colorectal cancer. The authors concluded that calcium after polypectomy was unlikely

2009 NHS Economic Evaluation Database.

200. Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men Full Text available with Trip Pro

Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men There is no consistent evidence, to our knowledge, that calcium supplementation affects bone mineral density (BMD) in men, despite male osteoporosis being a common clinical problem.To determine the effects of calcium supplementation (600 mg/d, 1200 mg/d, or placebo) on BMD in men, we conducted a double-blind, randomized controlled trial for a 2-year period at an academic clinical research center (...) . A total of 323 healthy men at least 40 years old (mean age, 57 years) were recruited by newspaper advertisement. Complete follow-up was achieved in 96% of subjects.The BMD increased at all sites in the group receiving calcium, 1200 mg/d, by 1% to 1.5% more than those receiving placebo. The results for the group receiving calcium, 600 mg/d, were not different from the placebo group at any BMD site. There was no interaction between the BMD treatment effect and either age or dietary calcium intake

2008 EvidenceUpdates Controlled trial quality: predicted high